|

Auxiliary Medicinal Product - Dexamethasone Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • MedSIR1

Indications

  • ESR1 Gene Mutation1
  • ER-positive Breast Cancer1
  • HER2-negative Breast Cancer1
  • Advanced Breast Cancer1
  • Breast Cancer1

Other1 trial

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.